Even in the 21st century, women are consistently underrepresented in clinical trials involving drug therapy, medical devices, and behavioral interventions. Although various US federal agencies have made improvements to legislation regarding women’s participation in clinical trials over the past few decades, recent studies demonstrate that the underrepresentation of women remains a persistent problem that raises [...]
“Placebos are the ghosts that haunt our house of biomedical objectivity, the creatures that rise up from the dark and expose the paradoxes and fissures in our own self-created definitions of the real and active factors in treatment”.1 So writes Harvard professor Anne Harrington, and today, the mysteries and contradictions generated by the placebo continue [...]